Miuraenamides: Antimicrobial cyclic depsipeptides isolated from a rare and slightly halophilic myxobacterium

Chemistry - An Asian Journal

Volumn 3, Issue 1, 2008, Pages 126-133

  Ojika, Makoto ^a   Inukai, Yasutaka ^a   Kito, Yuko ^a   Hirata, Masayuki ^a   Iizuka, Takashi ^b   Fudou, Ryosuke ^b  

^a NAGOYA UNIVERSITY   (Japan)

^b AJINOMOTO CO INC   (Japan)

Author keywords

Antibiotics; Peptides; Polyketides; Structure elucidation; Structure activity relationships

Indexed keywords

ANTIINFECTIVE AGENT; CYCLOPEPTIDE; DEPSIPEPTIDE;

ARTICLE; CHEMISTRY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; ISOLATION AND PURIFICATION; MYXOCOCCALES; NUCLEAR MAGNETIC RESONANCE;

ANTI-INFECTIVE AGENTS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DEPSIPEPTIDES; MYXOCOCCALES; NUCLEAR MAGNETIC RESONANCE, BIOMOLECULAR; PEPTIDES, CYCLIC;

EID: 38449106572     PISSN: 18614728     EISSN: 1861471X     Source Type: Journal    
DOI: 10.1002/asia.200700233     Document Type: Article

References (28)

1. a) H. Reichenbach, K. Gerth, H. Irschik, B. Kunze, G. Höfle, Trends Biotechnol. 1988, 6, 115-121;
2. b) H. Reichenbach, G. Höfle in Myxobacteria II (Eds.: M. Dworkin, D. Kaiser), American Society for Microbiology, Washington, 1993, pp. 347-397;
3. c) K. Gerth, S. Pradella, O. Perlova, S. Beyer, R. Müller, J. Biotechnol. 2003, 106, 233-253.
4. D. M. Bollag, P. A. McQueney, J. Zhu, O. Hensens, L. Koupal, J. Liesch, E. Goetz, E. Lazarides, C. M. Woods, Cancer Res. 1995, 55, 2325-2333.
5. a) A. Mancuso, S. Oudard, C. N. Sternberg, Crit. Rev. Oncol. Hematol. 2007, 61, 176-185;
6. b) J. M. G. Larkin, S. B. Kaye, Exp. Opin. Invest. Drugs 2006, 15, 691-702.
7. T. Iizuka, Y. Jojima, R. Fudou, S. Yamanaka, FEMS Microbiol. Lett. 1998, 169, 317-322.
8. a) Y.-Q. Zhang, Y.-Z. Li, B. Wang, Z.-H. Wu, C.-Y. Zhang, X. Gong, Z.-J. Qiu, Y. Zhang, Appl. Environ. Microbiol. 2005, 71, 3331-3336;
9. b) T. Iizuka, Y. Jojima, R. Fudou, A. Hiraishi, J.-W. Ahn, S. Yamanaka, Int. J. Syst. Evol. Microbiol. 2003, 53, 189-195;
10. c) T. Iizuka, Y. Jojima, R. Fudou, M. Tokura, A. Hiraishi, S. Yamanaka, Syst. Appl. Microbiol. 2003, 26, 189-196;
11. d) R. Fudou, Y. Jojima, T. Iizuka, S. Yamanaka, J. Gen. Appl. Microbiol. 2002, 48, 109-115;
12. e) J. Zhang, Z. Liu, S. Wang, P. Jiang, Appl. Microbiol. Biotechnol. 2002, 59, 517-522.
13. a) R. Fudou, T. Iizuka, S. Yamanaka, J. Antibiot. 2001, 54, 149-152;
14. b) R. Fudou, T. Iizuka, S. Sato, T. Ando, N. Shimba, S. Yamanaka, J. Antibiot. 2001, 54, 153-156;
15. c) B. A. Kundim, Y. Itou, Y. Sakagami, R. Fudou, T. Iizuka, S. Yamanaka, M. Ojika, J. Antibiot. 2003, 56, 630-638.
16. T. Iizuka, R. Fudou, S. Ogawa, S. Yamanaka, Y. Inukai, M. Ojika, J. Antibiot. 2006, 59, 385-391.
17. I. Ohtani, T. Kusumi, Y. Kashman, H. Kakisawa, J. Am. Chem. Soc. 1991, 113, 4092-4096.
18. K. Fujii, Y. Ikai, H. Oka, M. Suzuki, K. Harada, Anal. Chem. 1997, 69, 5146-5151.
19. H. Sauter, W. Steglich, T. Anke, Angew. Chem. 1999, 111, 1416-1438;
20. Angew. Chem. Int. Ed. 1999, 38, 1328-1349.
21. G. Thierbach, H. Reichenbach, Biochim. Biophys. Acta Bioenerg. 1981, 638, 282-289.
22. M. Ojika, Y. Suzuki, A. Tsukamoto, Y. Sakagami, R. Fudou, T. Yoshimura, S. Yamanaka, J. Antibiot. 1998, 51, 275-281.
23. a) B. Böhlendorf, M. Harrmann, H.-J. Hecht, F. Sasse, E. Forche, B. Kunze, H. Reichenbach, G. Höfle, Eur. J. Org. Chem. 1999, 2601-2608;
24. b) T. Anke, W. Steglich in Drug Discovery from Nature (Eds.: S. Grabley, R. Thiericke), Springer, Berlin, 1999, pp. 320-334.
25. a) W. R. Chan, W. F. Tinto, P. S. Manchand, L. J. Todaro, J. Org. Chem. 1987, 52, 3091-3093;
26. b) J. E. Coleman, R. V. Soest, R. J. Andersen, J. Nat. Prod. 1999, 62, 1137-1141, and references therein.
27. C. Tanaka, J. Tanaka, R. F. Bolland, G. Marriott, T. Higa, Tetrahedron 2006, 62, 3536-3542.
28. H. Ishiwata, T. Nemoto, M. Ojika, K. Yamada, J. Org. Chem. 1994, 59, 4710-4711.